Feb 22, 2021
Miravo Healthcare(TM) Announces Fourth Quarter 2020 Results Release Date and Conference Call Details
Jan 14, 2021
Miravo Healthcare(TM) to Host Investor Webcast on January 28, 2021 at 2:00 p.m. EST
Jan 13, 2021
Miravo Healthcare(TM) Announces the Canadian Commercial Launch of NeoVisc®+ and NeoVisc® ONE for the Treatment of Pain and Improvement of Joint Functionality of the Knee
Dec 21, 2020
Miravo Healthcare(TM) Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets
Dec 18, 2020
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare(TM)
Nov 16, 2020
Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results
Nov 02, 2020
Nuvo Pharmaceuticals(TM) Announces Third Quarter 2020 Results Release Date and Conference Call Details
Oct 05, 2020
Nuvo Pharmaceuticals® to Webcast Live at VirtualInvestorConferences.com October 8th
Sep 14, 2020
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th
Sep 09, 2020
Nuvo Pharmaceuticals® Announces The Canadian Commercial Launch of Suvexx(TM) - For The Acute Treatment of Migraine
Aug 10, 2020
Nuvo Pharmaceuticals® Announces Second Quarter 2020 Results
Jul 27, 2020
Nuvo Pharmaceuticals(TM) Announces Second Quarter 2020 Results Release Date and Conference Call Details
May 12, 2020
Nuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders
May 11, 2020
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results
Apr 27, 2020
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results Release Date and Virtual Annual & Special Meeting of Shareholders
Mar 31, 2020
Nuvo Pharmaceuticals® Announces Approval of Takeda's Cabpirin Tablets in Japan, Triggering a US$2.0 Million Milestone Payment due in Q2 2020
Mar 23, 2020
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum March 26th
Mar 04, 2020
Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States
Feb 27, 2020
Nuvo Pharmaceuticals® Announces Health Canada Approves Suvexx(TM) For The Acute Treatment of Migraine
Feb 25, 2020
Nuvo Pharmaceuticals® Announces 2019 and Fourth Quarter Results